尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Russell Steven Jon. Director active across 1 company, notably Beta Bionics, Inc.. Aggregated, 7 disclosures have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €162k. Activity tracked since 27 February 2025. The latest transaction was disclosed on 2 September 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Russell Steven Jon is a declarant linked to Beta Bionics, Inc., where he is Chief Medical Officer. He has made 6 filings in total, and across the 6 most recent filings tracked, the transactions are sales for EUR 92425 between 2025-03-03 and 2026-06-03.